BASSETTI, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 33.367
Totale 33.367
Nazione #
IT - Italia 33.367
Totale 33.367
Città #
Genova 22.010
Genoa 3.975
Vado Ligure 3.696
Rapallo 3.573
Bordighera 113
Totale 33.367
Nome #
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 246
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit 176
Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals. 173
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 170
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 147
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. 145
An Italian consensus for invasive candidiasis management (ITALIC). 143
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 142
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. 141
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. 141
Invasive candidiasis in non-hematological patients. 141
Possible malignant transformation of benign lymphoepithelial parotid lesions in human immunodeficiency virus-infected patients: report of three cases. 139
Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates in an Italian hospital. 138
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 138
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 137
Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy 134
Pulmonary cryptococcosis with severe eosinophilia in an immunocompetent patient. 133
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 133
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. 133
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment 131
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 129
Use of colistin in adult patients: a cross-sectional study 128
Invasive pulmonary aspergillosis in intensive care units: is it a real problem? 127
Candidaemia in internal medicine departments: the burden of a rising problem. 126
A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies 126
Will new antimicrobials overcome resistance among Gram-negatives? 125
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 125
Infective endocarditis in elderly: An Italian prospective multi-center observational study 123
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 123
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. 123
Management of KPC-producing Klebsiella pneumoniae infections 123
Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration 122
Primary varicella zoster infection associated with fingolimod treatment. 122
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 122
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). 121
High-dose daptomycin in documented Staphylococcus aureus infections. 121
Post-operative abdominal infections: epidemiology, operational definitions, and outcomes 121
Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children 119
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. 119
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 119
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 118
Treatment of Infections Due to MDR Gram-Negative Bacteria 117
Pseudomonas aeruginosa serious infections: mono or combination antimicrobial therapy? 116
Monitoraggio della gestione pre ed intra-operatoria del paziente sottoposto ad intervento chirurgico presso l’A.O.U. San Martino di Genova 116
Sequentialoutbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation 116
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 115
Tigecycline use in serious nosocomial infections: a drug use evaluation. 115
Current status of newer carbapenems 111
A case report of Absidia corymbifera soft-tissue infection with kidney involvement in a AIDS patient. 111
Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy 111
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 110
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 109
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 109
Antimicrobial use and resistance among gram-negative bacilli in an italian intensive care unit (ICU) 108
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study-authors' response 108
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 108
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients 108
Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B 107
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. 107
Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort. 107
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 107
Novel beta-lactam antibiotics and inhibitor combinations. Expert Opin Investig Drugs 106
Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies 106
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 106
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 106
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. 105
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 105
Hospital-Acquired Infections and Leading Pathogens Detected in a Regional University Adult Acute-care Hospital in Genoa, Liguria, Italy: Results from a Prevalence Study 104
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. 104
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 104
Soft-tissue infection with Absidia corymbifera and kidney complications in an AIDS patient. 103
Moxifloxacin in the treatment of hospitalised community acquired pneumonia in HIV-infected subjects 103
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 103
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 103
Risk factors andmortality of healthcare-associated and community-acquired Staphylococcus aureusbacteraemia 102
null 102
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 102
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections 102
Clinical and therapeutic aspects of candidemia: A five year single centre study 102
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients with Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae 102
Epidemiological trends in nosocomial candidemia in intensive care 101
Analysis of clinical data in patients with Girldstone arthroplasty: a new score 101
Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study 101
Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections 99
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 99
Ceftolozane/tazobactam: place in therapy 99
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 98
Predictors of Mortality in Bloodstream Infections Caused by KPC-Producing Klebsiella pneumoniae: Importance of Combination Therapy. 98
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 97
Benign lymphoepithelial parotid lesions in vertically HIV-infected patients 97
The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts 96
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 96
Why is community-associated MRSA spreading across the world and how will it change clinical practice? 95
Does the adoption of EUCAST susceptibility breackpoints affects the selection of antimicrobials to treat acute community-acquired respiratory tract infections? 95
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 95
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 95
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. 94
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumba 94
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 93
New treatment options against gram-negative organisms. 93
Totale 11.685
Categoria #
all - tutte 145.493
article - articoli 143.518
book - libri 0
conference - conferenze 701
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.274
Totale 290.986


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.811 0 0 0 0 0 0 1.812 1.196 1.422 1.895 1.085 401
2020/20214.621 219 562 454 365 359 289 283 509 360 639 255 327
2021/20225.262 247 177 192 536 168 382 385 1.168 645 430 266 666
2022/20234.543 559 328 55 385 575 605 139 314 822 216 440 105
2023/20242.875 137 327 79 320 234 411 185 181 152 111 222 516
2024/20254.215 235 739 236 533 1.411 1.029 32 0 0 0 0 0
Totale 34.647